To print: Select File and then Print from your browser's menu

Title: Bleomycin Successful In Treating Resistant Hand Warts

URL: http://www3.interscience.wiley.com/cgi-bin/abstract/90510950/START

Lasers Surg. Med. 30:135-140, 2002. "Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts"
03/20/2002 11:03:45 AM
By David Ball

Resistant hand warts and warts found in difficult sites in immunosuppressed patients can be successfully treated by combining pulsed dye laser and intralesional bleomycin. Initial treatment with pulsed dye laser prepares the wart for the bleomycin injection and ensures it goes into the base of the wart to minimise the risk of infiltration of normal skin. This new technique for safely administrating bleomycin into warts was tested by two investigators at Leeds Laser Centre, Leeds General Infirmary, England. Their open study of ten patients with resistant viral hand warts of at least three years duration included four on long-term immunosuppressant drugs. A total of 18 warts were treated. Following anaesthesia with 1% lignocaine to the local area, warts were treated with a pulsed dye laser (7 mm spot, fluence 10 J/cm²). Bleomycin (0.5 IU/ml) was then injected into the base of the wart and subjects were followed-up with monthly treatment. All eight warts in the six immunocompetent subjects were successfully cleared, as were eight out of ten warts in the immunosuppressed patients. In total, all but two of the 18 warts, 89 percent, were cleared. While the remaining two warts partially responded to two treatments, no further therapy was given because the patient was happy with the result. There were no serious side effects in any of the subjects. The researchers point out that viral warts, some of which are resistant to multiple therapies particularly in immunosuppressed patients, affect 7 - 10 percent of the population and can be a major burden on dermatology departments. They found the combination of pulsed dye laser and intralesional bleomycin was safe, rapid and well tolerated but suggest a larger controlled study is needed to confirm these findings.

http://www3.interscience.wiley.com/cgi-bin/abstract/90510950/START

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.